We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Brown & Brown Poised for Growth Despite Higher Expenses
Read MoreHide Full Article
On Jun 10, 2016, we issued an updated research report on Brown & Brown Inc. (BRO - Free Report) .
The insurance broker’s first-quarter 2016 earnings outperformed the Zacks Consensus Estimate and also increased year over year on higher revenues. Moreover, the company estimates EBITDAC margins between 33% and 35% over the long term.
Brown & Brown’s performance remains impressive both in terms of organic and inorganic growth across all its segments. Also, strategic acquisitions and mergers help the company expand its operations. In the first quarter, the insurance broker acquired three companies with annualized revenues of $14.5 million.
Further, a strong capital and liquidity position enables the insurer to enhance shareholder value through dividend increases and share buybacks. Also, the $75 million accelerated share repurchase (ASR) program that commenced in the fourth quarter of 2015 was completed in January. Post completion of the ASR, the company has $375 million remaining under its authorization.
However, the company has been witnessing escalating expenses over the past few quarter due to higher employee compensation and other operating expenses. This has, in turn, adversely affected the company’s margins.
In addition, Brown & Brown generates a major portion of its commission revenues from a limited number of insurance companies. Failure to retain any of these clients might hurt the company’s top line, and result in lower market share and higher expenses.
Zacks Rank and Stocks to Consider
Currently, Brown & Brown carries a Zacks Rank #3 (Hold). Some better-ranked stocks from the insurance industry are Hannover Rück SE (HVRRY - Free Report) , Marsh & McLennan Companies, Inc. (MMC - Free Report) and Markel Corp. (MKL - Free Report) . While both Hannover Rück and Marsh & McLennan hold a Zacks Rank #2 (Buy), Markel Corp. sports a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
Brown & Brown Poised for Growth Despite Higher Expenses
On Jun 10, 2016, we issued an updated research report on Brown & Brown Inc. (BRO - Free Report) .
The insurance broker’s first-quarter 2016 earnings outperformed the Zacks Consensus Estimate and also increased year over year on higher revenues. Moreover, the company estimates EBITDAC margins between 33% and 35% over the long term.
Brown & Brown’s performance remains impressive both in terms of organic and inorganic growth across all its segments. Also, strategic acquisitions and mergers help the company expand its operations. In the first quarter, the insurance broker acquired three companies with annualized revenues of $14.5 million.
Further, a strong capital and liquidity position enables the insurer to enhance shareholder value through dividend increases and share buybacks. Also, the $75 million accelerated share repurchase (ASR) program that commenced in the fourth quarter of 2015 was completed in January. Post completion of the ASR, the company has $375 million remaining under its authorization.
However, the company has been witnessing escalating expenses over the past few quarter due to higher employee compensation and other operating expenses. This has, in turn, adversely affected the company’s margins.
In addition, Brown & Brown generates a major portion of its commission revenues from a limited number of insurance companies. Failure to retain any of these clients might hurt the company’s top line, and result in lower market share and higher expenses.
Zacks Rank and Stocks to Consider
Currently, Brown & Brown carries a Zacks Rank #3 (Hold). Some better-ranked stocks from the insurance industry are Hannover Rück SE (HVRRY - Free Report) , Marsh & McLennan Companies, Inc. (MMC - Free Report) and Markel Corp. (MKL - Free Report) . While both Hannover Rück and Marsh & McLennan hold a Zacks Rank #2 (Buy), Markel Corp. sports a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>